APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glucagon Like Peptide 2 Receptor

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Glucagon Like Peptide 2 Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025187 pages

Choose your research edition.

Industry ResearchGlucagon Like Peptide 2 Receptor Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Glucagon Like Peptide 2 Receptor Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Glucagon Like Peptide 2 Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glucagon Like Peptide 2 Receptor Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Glucagon Like Peptide 2 Receptor Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Glucagon Like Peptide 2 Receptor market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Glucagon Like Peptide 2 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Glucagon Like Peptide 2 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glucagon Like Peptide 2 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Glucagon Like Peptide 2 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Glucagon Like Peptide 2 Receptor include Takeda, Tasly Pharmaceutical Group Co Ltd, Hanmi Pharmaceuticals Co Ltd, Zealand Pharma AS and Naia Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Glucagon Like Peptide 2 Receptor market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Glucagon Like Peptide 2 Receptor and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glucagon Like Peptide 2 Receptor sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glucagon Like Peptide 2 Receptor market size, projected growth trends, production technologies, key applications, and end-use industries.

Glucagon Like Peptide 2 Receptor Segment by Company

Takeda

Tasly Pharmaceutical Group Co Ltd

Hanmi Pharmaceuticals Co Ltd

Zealand Pharma AS

Naia Ltd

Glucagon Like Peptide 2 Receptor Segment by Type

FE-203799

GXG-8

HM-15910

Glepaglutide

Others

Glucagon Like Peptide 2 Receptor Segment by Application

Diabetes

Diarrhea

Obesity

Short Bowel Syndrome

Others

Glucagon Like Peptide 2 Receptor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucagon Like Peptide 2 Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glucagon Like Peptide 2 Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucagon Like Peptide 2 Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Glucagon Like Peptide 2 Receptor market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Glucagon Like Peptide 2 Receptor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Glucagon Like Peptide 2 Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Glucagon Like Peptide 2 Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Glucagon Like Peptide 2 Receptor Industry Trends Table 2. Glucagon Like Peptide 2 Receptor Industry Drivers Table 3. Glucagon Like Peptide 2 Receptor Industry Opportunities and Challenges Table 4. Glucagon Like Peptide 2 Receptor Industry Restraints Table 5. Global Glucagon Like Peptide 2 Receptor Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Glucagon Like Peptide 2 Receptor Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Manufacturers Table 9. Global Glucagon Like Peptide 2 Receptor Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Glucagon Like Peptide 2 Receptor Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Glucagon Like Peptide 2 Receptor Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Glucagon Like Peptide 2 Receptor Manufacturers, Product Type & Application Table 13. Global Glucagon Like Peptide 2 Receptor Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Glucagon Like Peptide 2 Receptor by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of FE-203799 Table 17. Major Manufacturers of GXG-8 Table 18. Major Manufacturers of HM-15910 Table 19. Major Manufacturers of Glepaglutide Table 20. Major Manufacturers of Others Table 21. Global Glucagon Like Peptide 2 Receptor Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 22. Global Glucagon Like Peptide 2 Receptor Sales by Type (2021-2026) & (W Units) Table 23. Global Glucagon Like Peptide 2 Receptor Sales by Type (2027-2032) & (W Units) Table 24. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Type (2021-2026) Table 25. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Type (2027-2032) Table 26. Global Glucagon Like Peptide 2 Receptor Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 27. Global Glucagon Like Peptide 2 Receptor Revenue by Type (2021-2026) & (W Units) Table 28. Global Glucagon Like Peptide 2 Receptor Revenue by Type (2027-2032) & (W Units) Table 29. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Type (2021-2026) Table 30. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Diabetes Table 32. Major Manufacturers of Diarrhea Table 33. Major Manufacturers of Obesity Table 34. Major Manufacturers of Short Bowel Syndrome Table 35. Major Manufacturers of Others Table 36. Global Glucagon Like Peptide 2 Receptor Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 37. Global Glucagon Like Peptide 2 Receptor Sales by Application (2021-2026) & (W Units) Table 38. Global Glucagon Like Peptide 2 Receptor Sales by Application (2027-2032) & (W Units) Table 39. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Application (2021-2026) Table 40. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Application (2027-2032) Table 41. Global Glucagon Like Peptide 2 Receptor Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 42. Global Glucagon Like Peptide 2 Receptor Revenue by Application (2021-2026) & (W Units) Table 43. Global Glucagon Like Peptide 2 Receptor Revenue by Application (2027-2032) & (W Units) Table 44. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Application (2021-2026) Table 45. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Application (2027-2032) Table 46. Global Glucagon Like Peptide 2 Receptor Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 47. Global Glucagon Like Peptide 2 Receptor Sales by Region (2021-2026) & (W Units) Table 48. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Region (2021-2026) Table 49. Global Glucagon Like Peptide 2 Receptor Sales Forecasted by Region (2027-2032) & (W Units) Table 50. Global Glucagon Like Peptide 2 Receptor Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Glucagon Like Peptide 2 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 52. North America Glucagon Like Peptide 2 Receptor Sales by Country (2021-2026) & (W Units) Table 53. North America Glucagon Like Peptide 2 Receptor Sales by Country (2027-2032) & (W Units) Table 54. Europe Glucagon Like Peptide 2 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Europe Glucagon Like Peptide 2 Receptor Sales by Country (2021-2026) & (W Units) Table 56. Europe Glucagon Like Peptide 2 Receptor Sales by Country (2027-2032) & (W Units) Table 57. Asia Pacific Glucagon Like Peptide 2 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. Asia Pacific Glucagon Like Peptide 2 Receptor Sales by Country (2021-2026) & (W Units) Table 59. Asia Pacific Glucagon Like Peptide 2 Receptor Sales by Country (2027-2032) & (W Units) Table 60. South America, Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 61. South America, Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Country (2021-2026) & (W Units) Table 62. South America, Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Country (2027-2032) & (W Units) Table 63. Global Glucagon Like Peptide 2 Receptor Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Glucagon Like Peptide 2 Receptor Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Glucagon Like Peptide 2 Receptor Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Region (2021-2026) Table 67. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Region (2027-2032) Table 68. Takeda Company Information Table 69. Takeda Business Overview Table 70. Takeda Glucagon Like Peptide 2 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Takeda Glucagon Like Peptide 2 Receptor Product Portfolio Table 72. Takeda Recent Development Table 73. Tasly Pharmaceutical Group Co Ltd Company Information Table 74. Tasly Pharmaceutical Group Co Ltd Business Overview Table 75. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Product Portfolio Table 77. Tasly Pharmaceutical Group Co Ltd Recent Development Table 78. Hanmi Pharmaceuticals Co Ltd Company Information Table 79. Hanmi Pharmaceuticals Co Ltd Business Overview Table 80. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Product Portfolio Table 82. Hanmi Pharmaceuticals Co Ltd Recent Development Table 83. Zealand Pharma AS Company Information Table 84. Zealand Pharma AS Business Overview Table 85. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Product Portfolio Table 87. Zealand Pharma AS Recent Development Table 88. Naia Ltd Company Information Table 89. Naia Ltd Business Overview Table 90. Naia Ltd Glucagon Like Peptide 2 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Naia Ltd Glucagon Like Peptide 2 Receptor Product Portfolio Table 92. Naia Ltd Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Glucagon Like Peptide 2 Receptor Distributors List Table 96. Glucagon Like Peptide 2 Receptor Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Glucagon Like Peptide 2 Receptor Product Image Figure 2. Global Glucagon Like Peptide 2 Receptor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glucagon Like Peptide 2 Receptor Market Size (2021-2032) & (US$ Million) Figure 4. Global Glucagon Like Peptide 2 Receptor Sales (2021-2032) & (W Units) Figure 5. Global Glucagon Like Peptide 2 Receptor Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Glucagon Like Peptide 2 Receptor Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. FE-203799 Image Figure 9. GXG-8 Image Figure 10. HM-15910 Image Figure 11. Glepaglutide Image Figure 12. Others Image Figure 13. Global Glucagon Like Peptide 2 Receptor Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Glucagon Like Peptide 2 Receptor Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Type (2021-2032) Figure 16. Global Glucagon Like Peptide 2 Receptor Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 17. Global Glucagon Like Peptide 2 Receptor Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Type (2021-2032) Figure 19. Diabetes Image Figure 20. Diarrhea Image Figure 21. Obesity Image Figure 22. Short Bowel Syndrome Image Figure 23. Others Image Figure 24. Global Glucagon Like Peptide 2 Receptor Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 25. Global Glucagon Like Peptide 2 Receptor Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Application (2021-2032) Figure 27. Global Glucagon Like Peptide 2 Receptor Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 28. Global Glucagon Like Peptide 2 Receptor Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Application (2021-2032) Figure 30. North America Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 31. North America Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2021-2032) Figure 32. U.S. Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Canada Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Mexico Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Europe Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Europe Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2021-2032) Figure 37. Germany Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 38. France Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 39. U.K. Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Italy Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Netherlands Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Asia Pacific Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Asia Pacific Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2021-2032) Figure 44. China Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Japan Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South Korea Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 47. Southeast Asia Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 48. India Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Australia Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 50. South America, Middle East and Africa Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 51. South America, Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2021-2032) Figure 52. Brazil Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 53. South Africa Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Saudi Arabia Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Turkey Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Argentina Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 57. UAE Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 58. Egypt Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 59. Chile Glucagon Like Peptide 2 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 60. Global Glucagon Like Peptide 2 Receptor Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Glucagon Like Peptide 2 Receptor Revenue (2021-2032) & (US$ Million) Figure 63. North America Glucagon Like Peptide 2 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Glucagon Like Peptide 2 Receptor Revenue (2021-2032) & (US$ Million) Figure 65. Europe Glucagon Like Peptide 2 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Glucagon Like Peptide 2 Receptor Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Glucagon Like Peptide 2 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Glucagon Like Peptide 2 Receptor Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Glucagon Like Peptide 2 Receptor Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • FE-203799
  • GXG-8
  • HM-15910
  • Glepaglutide
  • Others
Applications
  • Diabetes
  • Diarrhea
  • Obesity
  • Short Bowel Syndrome
  • Others
Companies covered
  • Takeda
  • Tasly Pharmaceutical Group Co Ltd
  • Hanmi Pharmaceuticals Co Ltd
  • Zealand Pharma AS
  • Naia Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Glucagon Like Peptide 2 Receptor Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Glucagon Like Peptide 2 Receptor Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Glucagon Like Peptide 2 Receptor Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Glucagon Like Peptide 2 Receptor Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Glucagon Like Peptide 2 Receptor Market Dynamics
  1. 2.1 Glucagon Like Peptide 2 Receptor Industry Trends
  2. 2.2 Glucagon Like Peptide 2 Receptor Industry Drivers
  3. 2.3 Glucagon Like Peptide 2 Receptor Industry Opportunities and Challenges
  4. 2.4 Glucagon Like Peptide 2 Receptor Industry Restraints
3 Glucagon Like Peptide 2 Receptor Market by Manufacturers
  1. 3.1 Global Glucagon Like Peptide 2 Receptor Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Glucagon Like Peptide 2 Receptor Sales by Manufacturers (2021-2026)
  3. 3.3 Global Glucagon Like Peptide 2 Receptor Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Glucagon Like Peptide 2 Receptor Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Glucagon Like Peptide 2 Receptor Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Glucagon Like Peptide 2 Receptor Manufacturers, Product Type & Application
  7. 3.7 Global Glucagon Like Peptide 2 Receptor Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Glucagon Like Peptide 2 Receptor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Glucagon Like Peptide 2 Receptor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Glucagon Like Peptide 2 Receptor Tier 1, Tier 2, and Tier 3
4 Glucagon Like Peptide 2 Receptor Market by Type
  1. 4.1 Glucagon Like Peptide 2 Receptor Type Introduction
  2. 4.1.1 FE-203799
  3. 4.1.2 GXG-8
  4. 4.1.3 HM-15910
  5. 4.1.4 Glepaglutide
  6. 4.1.5 Others
  7. 4.2 Global Glucagon Like Peptide 2 Receptor Sales by Type
  8. 4.2.1 Global Glucagon Like Peptide 2 Receptor Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Glucagon Like Peptide 2 Receptor Sales by Type (2021-2032)
  10. 4.2.3 Global Glucagon Like Peptide 2 Receptor Sales Market Share by Type (2021-2032)
  11. 4.3 Global Glucagon Like Peptide 2 Receptor Revenue by Type
  12. 4.3.1 Global Glucagon Like Peptide 2 Receptor Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Glucagon Like Peptide 2 Receptor Revenue by Type (2021-2032)
  14. 4.3.3 Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Type (2021-2032)
5 Glucagon Like Peptide 2 Receptor Market by Application
  1. 5.1 Glucagon Like Peptide 2 Receptor Application Introduction
  2. 5.1.1 Diabetes
  3. 5.1.2 Diarrhea
  4. 5.1.3 Obesity
  5. 5.1.4 Short Bowel Syndrome
  6. 5.1.5 Others
  7. 5.2 Global Glucagon Like Peptide 2 Receptor Sales by Application
  8. 5.2.1 Global Glucagon Like Peptide 2 Receptor Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Glucagon Like Peptide 2 Receptor Sales by Application (2021-2032)
  10. 5.2.3 Global Glucagon Like Peptide 2 Receptor Sales Market Share by Application (2021-2032)
  11. 5.3 Global Glucagon Like Peptide 2 Receptor Revenue by Application
  12. 5.3.1 Global Glucagon Like Peptide 2 Receptor Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Glucagon Like Peptide 2 Receptor Revenue by Application (2021-2032)
  14. 5.3.3 Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Application (2021-2032)
6 Global Glucagon Like Peptide 2 Receptor Sales by Region
  1. 6.1 Global Glucagon Like Peptide 2 Receptor Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Glucagon Like Peptide 2 Receptor Sales by Region (2021-2032)
  3. 6.2.1 Global Glucagon Like Peptide 2 Receptor Sales by Region (2021-2026)
  4. 6.2.2 Global Glucagon Like Peptide 2 Receptor Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Glucagon Like Peptide 2 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Glucagon Like Peptide 2 Receptor Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Glucagon Like Peptide 2 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Glucagon Like Peptide 2 Receptor Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Glucagon Like Peptide 2 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Glucagon Like Peptide 2 Receptor Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Glucagon Like Peptide 2 Receptor Revenue by Region
  1. 7.1 Global Glucagon Like Peptide 2 Receptor Revenue by Region
  2. 7.1.1 Global Glucagon Like Peptide 2 Receptor Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Glucagon Like Peptide 2 Receptor Revenue by Region (2021-2026)
  4. 7.1.3 Global Glucagon Like Peptide 2 Receptor Revenue by Region (2027-2032)
  5. 7.1.4 Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Glucagon Like Peptide 2 Receptor Revenue (2021-2032)
  8. 7.2.2 North America Glucagon Like Peptide 2 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Glucagon Like Peptide 2 Receptor Revenue (2021-2032)
  11. 7.3.2 Europe Glucagon Like Peptide 2 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Glucagon Like Peptide 2 Receptor Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Glucagon Like Peptide 2 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Glucagon Like Peptide 2 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Glucagon Like Peptide 2 Receptor Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Tasly Pharmaceutical Group Co Ltd
  8. 8.2.1 Tasly Pharmaceutical Group Co Ltd Company Information
  9. 8.2.2 Tasly Pharmaceutical Group Co Ltd Business Overview
  10. 8.2.3 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Product Portfolio
  12. 8.2.5 Tasly Pharmaceutical Group Co Ltd Recent Developments
  13. 8.3 Hanmi Pharmaceuticals Co Ltd
  14. 8.3.1 Hanmi Pharmaceuticals Co Ltd Company Information
  15. 8.3.2 Hanmi Pharmaceuticals Co Ltd Business Overview
  16. 8.3.3 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Product Portfolio
  18. 8.3.5 Hanmi Pharmaceuticals Co Ltd Recent Developments
  19. 8.4 Zealand Pharma AS
  20. 8.4.1 Zealand Pharma AS Company Information
  21. 8.4.2 Zealand Pharma AS Business Overview
  22. 8.4.3 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Product Portfolio
  24. 8.4.5 Zealand Pharma AS Recent Developments
  25. 8.5 Naia Ltd
  26. 8.5.1 Naia Ltd Company Information
  27. 8.5.2 Naia Ltd Business Overview
  28. 8.5.3 Naia Ltd Glucagon Like Peptide 2 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Naia Ltd Glucagon Like Peptide 2 Receptor Product Portfolio
  30. 8.5.5 Naia Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Glucagon Like Peptide 2 Receptor Value Chain Analysis
  2. 9.1.1 Glucagon Like Peptide 2 Receptor Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Glucagon Like Peptide 2 Receptor Production Mode & Process
  6. 9.2 Glucagon Like Peptide 2 Receptor Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Glucagon Like Peptide 2 Receptor Distributors
  9. 9.2.3 Glucagon Like Peptide 2 Receptor Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst